Information

We have had a great pleasure to participate in the 14th National Congress of the Austrian Society of Nuclear Medicine … Czytaj więcej…

The 35th Annual Congress of the European Association of Nuclear Medicine (EANM) in Barcelona was a huge success, gathering 7233 … Czytaj więcej…

On 4th of October we had a pleasure of hosting the first plenary meeting of #TOURR project with a visit … Czytaj więcej…

Started! On October 5th 2022, the SECURE project was launched in Warsaw, with the aim to ensure the availability of … Czytaj więcej…

Congratulations to our POLATOM’s R&D team! We have been granted US 11,426,395 B2 patent for PSMA-T4 kit for 99mTc labelling. … Czytaj więcej…

POLATOM makes every effort to guarantee production and delivery schedules of our I-131 pharmaceutical products. We are not stopping nor slowing down our production and contractual obligations for the planned maintenance of our production facility.… Czytaj więcej…

National Center for Nuclear Research The Polatom Radioisotope Center received funding from the European Commission (EC-Euratom) under the Horizon Europe … Czytaj więcej…

Anyone interested in the course “Staff dose reduction in the treatment of Lu-177, Ga-68, Y-90 and I-131” organized by our … Czytaj więcej…

We are counting down the days to the 35th Annual Congress of the European Association of Nuclear Medicine on October … Czytaj więcej…

POLATOM delegation is attending the 2022 Annual Meeting of Society of Nuclear Medicine & Molecular Imaging in Vancouver. The SNMMI … Czytaj więcej…

Radioisotope Centre POLATOM is the proud sponsor of the very 1st Conference of the Nuclear Cardiology Section of the Polish Cardiac … Czytaj więcej…

During the 17th Congress of the Polish Society of Nuclear Medicine in Białystok on May 26-28, 2022, a group of … Czytaj więcej…